SNIPR Biome

SNIPR Biome is a clinical-stage company developing precision medicines for patients with difficult-to-treat conditions

An artists depiction of E coli one of the many bacteria that is becoming resistant to first-line antibiotics The bacteria
Research

Small biotech turns CRISPR against bacteria

Can CRISPR—a gene editing mechanism born from bacteria—be used as an antibiotic? That’s what SNIPR Biome seems to have found in an early study.
Annalee Armstrong May 31, 2023 10:50am